Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerTFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer.Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers.A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas.Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.Trefoil factor family peptides TFF1 and TFF3 in the nervous tissues of developing mouse embryo.The interconnectedness of cancer cell signaling.Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2.Forced Trefoil Factor Family Peptide 3 (TFF3) Expression Reduces Growth, Viability, and Tumorigenicity of Human Retinoblastoma Cell Lines.Trefoil factor 3 as a novel biomarker to distinguish between adenocarcinoma and squamous cell carcinoma.ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.TFF3 knockout in human pituitary adenoma cell HP75 facilitates cell apoptosis via mitochondrial pathwayER and PR signaling nodes during mammary gland development.Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells.Trefoil factor family peptides--friends or foes?Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients.Identification of genomic signatures in circulating tumor cells from breast cancer.TFF2 deficiency exacerbates weight loss and alters immune cell and cytokine profiles in DSS colitis, and this cannot be rescued by wild-type bone marrow.Nuclear condensation and cell cycle arrest induced by telomerase siRNA in neuroblastoma cells.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationHypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells.Trefoil factor 3 contributes to the malignancy of glioma via regulating HIF-1α.Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.Increased immunoexpression of trefoil factors in salivary gland tumors.The association of trefoil factor 3 gene polymorphisms and haplotypes with unexplained female infertility: molecular insights into TFF3 regulation in receptive phase endometrium.Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells
P2860
Q24628746-FACD9FF3-3819-487B-8CE7-4589E359B993Q27853155-2EB514F4-D905-43BD-AAF4-225F474D8581Q33889185-3CCBD5FD-A1E7-492A-AFCD-AAE0457D299FQ33905866-8450D271-1ED5-45B4-9706-BEAAE67852F7Q34270766-3A2497E4-AD92-4ED4-A49F-1C804D45D265Q35000231-C3DEBE00-B940-47CC-BD44-08BCC4F41D50Q35194373-D443B964-4F59-40F2-96F0-6F9676788019Q35669733-D799BAF8-FF11-4696-B498-1D7FAF779AECQ35838937-B3224DD1-A484-4F5F-83D0-DA171CD30AFBQ36132170-BAEDC21C-EF12-45FC-A31B-F1EADFF787DEQ36152945-539AF6BB-825F-4C23-9D19-5B2ED09A797CQ36416481-EDA2B32B-795B-4901-8426-C3A8D47AB0EBQ36464509-45B40090-FAD4-4387-ABC1-DB5821C033FCQ36924384-52648BA5-1CBA-4C3E-9A89-6BDAE443A7DCQ37563940-EF19EBD9-D589-483D-98BB-5E03914843F7Q38610757-9B09F84E-1B87-446A-A63A-B2E0A57D89C7Q38818289-AFF184E0-800C-4E50-8353-87C0165BC1A3Q38926497-7C9CD28B-BCD7-4746-A302-F4E3D3AC2ACDQ39111716-86EDC27D-58DC-4541-9E28-FD8763B19B61Q39226403-8E3344F3-1413-4662-BACC-08A0B4371E89Q41879186-2ECE2351-2DC7-46CD-8454-FD48490AB06DQ43730260-4B3D5E4A-7046-474B-9113-CF5C6DD2FB66Q44854266-5BD4209B-DCBE-4D5A-9DC3-D6AF3A5074A1Q47114555-9009A6C2-F050-4A4F-A9C0-6ACC5DA6D47DQ47743907-9ACEB338-91CC-4305-BADF-801609D84E37Q51185337-E2556D8C-2CAA-4899-90DD-F7BD01931625Q59126395-34C70D6B-7572-4DE2-988E-9C1F7C11CED6
P2860
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@ast
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@en
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@nl
type
label
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@ast
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@en
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@nl
prefLabel
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@ast
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@en
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@nl
P2093
P2860
P356
P1433
P1476
Trefoil factor 3 is oncogenic ...... nce in human mammary carcinoma
@en
P2093
Dong-Xu Liu
Edison T Liu
Hichem C Mertani
Jianzhong Tang
Jo K Perry
Kumarasamypet M Mohankumar
Lance D Miller
Nagarajan Kannan
Peter E Lobie
P2860
P304
P356
10.1593/NEO.10916
P577
2010-12-01T00:00:00Z